Merck KGaA (Darmstadt, Germany), a privately-held pharmaceutical and specialist chemicals company, has acquired the assets of chromatographic column developer SeQuant AB (Umea, Sweden). "[The aquisition] offers Merck superb opportunities for the future expansion of the chromatography business," said Klaus Bischoff, head of the Performance and Life Science Chemicals division at Merck.
Merck KGaA (Darmstadt, Germany), a privately-held pharmaceutical and specialist chemicals company, has acquired the assets of chromatographic column developer SeQuant AB (Umea, Sweden). "[The aquisition] offers Merck superb opportunities for the future expansion of the chromatography business," said Klaus Bischoff, head of the Performance and Life Science Chemicals division at Merck. SeQuant is particulary known for its particle technology development for zwitterionic hydrophilic interaction chromatography, or ZIC(R)-HILIC, a proprietary concept that "markedly improves the separation of... chemical compounds," such as inorganic ions and polar organic ions, including peptides, according to the company.
LCGC’s Year in Review: Highlights in Liquid Chromatography
December 20th 2024This collection of technical articles, interviews, and news pieces delves into the latest innovations in LC methods, including advance in high performance liquid chromatography (HPLC), ultrahigh-pressure liquid chromatography (UHPLC), liquid chromatography–mass spectrometry (LC–MS), and multidimensional LC.
Next Generation Peak Fitting for Separations
December 11th 2024Separation scientists frequently encounter critical pairs that are difficult to separate in a complex mixture. To save time and expensive solvents, an effective alternative to conventional screening protocols or mathematical peak width reduction is called iterative curve fitting.